Cargando…

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma

Background: Long noncoding RNAs (lncRNAs) are significantly implicated in tumor proliferation. Nevertheless, proliferation-derived lncRNAs and their latent clinical significance remain largely unrevealed in hepatocellular carcinoma (HCC). Methods: This research enrolled 658 HCC patients from five in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chi, Gao, Jie, Yang, Dongjing, Yu, Qiwen, Zhang, Shuijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158467/ https://www.ncbi.nlm.nih.gov/pubmed/35662721 http://dx.doi.org/10.3389/fphar.2022.907433

Ejemplares similares

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
por: Zhang, Zeyu, et al.
Publicado: (2022)

Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma
por: Xu, Ke, et al.
Publicado: (2023)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
por: Zeng, Ying, et al.
Publicado: (2019)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma
por: Cheng, Zina, et al.
Publicado: (2022)

A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma
por: Zhang, Hai-Bo, et al.
Publicado: (2023)

Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
por: Hong, Weifeng, et al.
Publicado: (2020)

Identification and Characterization of an Ageing-Associated 13-lncRNA Signature That Predicts Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Li, Fulei, et al.
Publicado: (2023)

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
por: Xie, Tongjin, et al.
Publicado: (2022)

A Novel lncRNA Panel for Risk Stratification and Immune Landscape in Breast Cancer Patients
por: Li, Chen, et al.
Publicado: (2022)

Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma
por: Shi, Chuan-jian, et al.
Publicado: (2021)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

Title: Immunotherapy; a ground-breaking remedy for spinal cord injury with stumbling blocks: An overview
por: Saeed, Yasmeen
Publicado: (2023)

Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2022)

Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma
por: Ma, Shuai, et al.
Publicado: (2022)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
por: Meng, Zilu, et al.
Publicado: (2022)

Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer
por: Song, Xuesong, et al.
Publicado: (2022)

Immune cell death-related lncRNA signature as a predictive factor of clinical outcomes and immune checkpoints in gastric cancer
por: Zhang, Zeyu, et al.
Publicado: (2023)

A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy
por: Wang, Hao, et al.
Publicado: (2021)

LncRNA LINC01134 Contributes to Radioresistance in Hepatocellular Carcinoma by Regulating DNA Damage Response via MAPK Signaling Pathway
por: Wang, Zhiyi, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
por: Zhang, Mengzhe, et al.
Publicado: (2023)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Stratification of lncRNA modulation networks in breast cancer
por: Yu, Wen-Hsuan, et al.
Publicado: (2022)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer
por: Liu, Yilong, et al.
Publicado: (2022)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape
por: Li, Shiqi, et al.
Publicado: (2022)

Immunotherapies for advanced hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2023)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients
por: Zhang, Biao, et al.
Publicado: (2023)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer
por: Lin, Yaobin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c8trht0u350ulem3kppg139v3e